Home / Research Library / Precision Oncology, Signaling, and Anticancer Agen...
🧬 Medicine & Biology PubMed

Precision Oncology, Signaling, and Anticancer Agents in Cancer Therapeutics.

📅 January 1, 2022 👤 Advani Dia, Sharma Sudhanshu, Kumari Smita et al. 📖 Anti-cancer agents in medicinal chemistry

🤖 Plain-English Summary

The global alliance for genomics and healthcare facilities provides innovative solutions to expedite research and clinical practices for complex and incurable health conditions. The success story of this field in context to drug resistance, safety, patient survival, and improving quality of life is yet to be elucidated.

🔑 Key Findings

  • Precision oncology is an emerging field explicitly tailored to facilitate cancer diagnosis, prevention, and treatment based on patients' genetic profiles.
  • Advancements in "omics" techniques, next-generation sequencing, artificial intelligence, and clinical trial designs provide a platform for assessing the efficacy and safety of combination therapies and diagnostic procedures.
  • Data were collected from PubMed and Google Scholar using keywords "Precision medicine," "precision medicine and cancer," "anticancer agents in precision medicine," and reviewed comprehensively.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via PubMed.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Jan 01, 2022
Journal Anti-cancer agents in medicinal chemistry
Authors Advani Dia, Sharma Sudhanshu, Kumari Smita, Ambasta Rashmi K, Kumar Pravir
DOI 10.2174/1871520621666210308101029
Source PubMed

More 🧬 Medicine & Biology Research